Story · Medicine & Biotech
STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive
1 outlet · first reported by STAT News on
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today’s newsletter has a bit of everything: peptides, China, Congress, and cancer drugs. Biotech in 2026 is never dull. Hims and Noom take peptides further into mainstream… (STAT News)
Coverage, in order
-
STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arriveWant to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today’s newsletter has a bit of everything: peptides, China, Congress, and cancer drugs. Biotech in 2026 is never dull. Hims and Noom take peptides further into mainstream…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.